主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRBU
#3068
Caribou Biosciences, Inc. Common Stock
1.9
0
-1.55%
版块:
基础:
利润货币:
日范围
年范围
日变化
-1.55%
每月变动
+21.79%
6个月变化
-5.94%
年变化
+62.39%
前一天收盘价
1.9
3
Open
1.9
0
Bid
Ask
Low
1.9
0
High
1.9
0
交易量
25
市场
股票
医疗保健
CRBU
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
90.55 M
93 M
93 M
93.12 M
93.47 M
—
Valuation ratios
Enterprise value
145.51 M
131.58 M
55.51 M
92.13 M
206.64 M
485.86 M
Price to earnings ratio
-1.24
-0.96
-0.56
-0.71
-1.37
-3.61
Price to sales ratio
14.4
14.37
8.37
12.67
23.16
58.57
Price to cash flow ratio
1.37
1.04
0.6
0.87
1.71
4.22
Price to book ratio
0.13
0.57
0.08
0.13
0.28
1.05
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.1
0.11
0.15
0.24
0.14
0.65
Return on equity %
0.12
0.14
0.18
0.33
0.19
0.84
Return on invested capital %
140.93
148.48
215.16
—
301.94
—
Gross margin %
100
100
100
100
100
400
Operating margin %
1 889.23
1 871.69
1 823.76
1 783.95
1 337.58
6 816.98
EBITDA margin %
—
—
—
—
—
—
Net margin %
1 713.64
1 708.71
1 699.58
2 028.42
1 253.32
6 690.03
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.38
7.16
7.63
6.66
5.54
26.99
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.01
0.01
0.01
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
—
—
—
—
Long term debt to total equity ratio
—
0
—
—
—
—
Per share metrics
Operating cash flow per share
0.36
0.39
0.4
0.3
0.27
1.36
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
3.11
2.76
2.29
1.98
1.71
8.74
Net current asset value per share
2.62
2.43
2.34
2.07
1.67
8.51
Tangible book value per share
3.11
2.8
2.34
1.79
1.52
8.45
Working capital per share
2.27
2.09
2.04
1.76
1.37
7.25
Book value per share
3.11
2.8
2.34
1.79
1.52
8.45
新闻
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
Caribou Biosciences首席法务官出售1.36万美元CRBU股票
Caribou Biosciences CLO sold $13,598 in CRBU stock
Caribou Biosciences首席技术官Kelly出售6,100美元股票
Caribou Biosciences CTO Kelly sells $6.1k in shares
Caribou Biosciences首席医疗官出售价值2,100美元的CRBU股票
Caribou Biosciences首席商务官Khan出售1.36万美元股票
Caribou Biosciences CMO sells $2.1k in CRBU stock
Khan, Caribou Biosciences CBO, sells $13598 in stock
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates
Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year?